Han Ma
About Han Ma
Han Ma is the VP, Global Head of Safety Science & Epidemiology at BeiGene, based in San Mateo, California, with nearly two decades of experience in the biopharmaceutical industry.
Company
Han Ma is currently employed at BeiGene, a global biotechnology company focused on developing and commercializing innovative medicines to improve treatment outcomes for patients worldwide. The company operates under the mission of expanding access to innovative high-quality, affordable medicines. Han Ma serves as the Vice President and Global Head of Safety Science & Epidemiology, contributing significantly to the company's efforts from their San Mateo, California location.
Title
Han Ma holds the prominent title of Vice President, Global Head of Safety Science & Epidemiology at BeiGene. In this capacity, Han Ma is responsible for overseeing the safety and epidemiology efforts on a global scale, ensuring that the company's biopharmaceutical products meet the highest standards of safety and effectiveness.
Education and Expertise
Han Ma's extensive background in medicine and biotechnology is supported by their formal education and nearly two decades of industry experience. Han Ma earned a medical degree from Shanghai Medical College of Fudan University and pursued further studies to obtain a Ph.D. in molecular pathobiology from the University of Southern California. This academic foundation in medical sciences and molecular research underscores Han Ma's expertise in the field.
Background
Han Ma has accumulated nearly two decades of experience in the biopharmaceutical industry, with a significant portion of that time spent at Roche/Genentech. At Roche, Han Ma took on various leadership roles, including serving as Global Group Medical Director where they led a safety sciences team in Shanghai. Prior to their industry career, Han Ma worked as a clinical oncologist for 6 years, enriching their practical medical knowledge.
Professional Achievements
Since starting the role at BeiGene on June 1, 2021, Han Ma has been at the forefront of global safety science and epidemiology initiatives. With a rich career history, particularly a 20-year tenure at Roche/Genentech in notable leadership positions, Han Ma has consistently demonstrated leadership and expertise, significantly contributing to advancements in biopharmaceutical safety and innovation.